Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis-Reference-Cited by-全球学者库

Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis

Published:2020-07 Issue: Volume:96 Page:131-135
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Zhao Qianwen,Meng Meng,Kumar Rahul,Wu Yinlian,Huang Jiaofeng,Deng Yunlei,Weng Zhiyuan,Yang Li

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference30 articles.

1. From SARS to COVID-19: A previously unknown SARS- related coronavirus (SARS-CoV-2) of pandemic potential infecting humans - Call for a One Health approach;El Zowalaty;One health (Amsterdam, Netherlands),2020

2. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China;Hui;Int J Infect Dis,2020

3. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020. MMWR Morb Mortal Wkly Rep 2020; 69:343-6.

4. The SARS-CoV-2 outbreak: What we know;Wu;Int J Infect Dis,2020

5. The impact of COPD and smoking history on the severity of Covid-19: A systemic review and meta-analysis;Zhao;Journal of medical virology,2020

Cited by 374 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indicators of stress hematopoiesis in the blood predict COVID-19 progression in patients over 65 years old;Hematology;2024-02-02

2. The effects of Annual SZ drug on dynamic changes in lymphocytes and cytokines of COVID-19 patients: A randomized clinical trial;International Immunopharmacology;2024-02

3. The effect of a web-based lifestyle intervention on nutritional status and physical activity on prevention of COVID-19: a randomized controlled trial in women's empowerment;Frontiers in Nutrition;2024-01-19

4. Diabetic individuals with COVID-19 exhibit reduced efficacy of gliptins in inhibiting dipeptidyl peptidase 4 (DPP4). A suggested explanation for increased COVID-19 susceptibility in patients with type 2 diabetes mellitus (T2DM);Life Sciences;2024-01

5. The Intersection of COVID-19 and Rheumatoid Arthritis: Shared Mechanisms, Treatment Challenges, and Potential Therapeutic Approaches;aging and disease;2024